IRIS
ANNESE, VITO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 944
NA - Nord America 212
AS - Asia 50
OC - Oceania 1
Totale 1.207
Salva come PNG Salva come JPEG
Nazione #
CZ - Repubblica Ceca 826
US - Stati Uniti d'America 210
SE - Svezia 56
CN - Cina 27
FI - Finlandia 24
IT - Italia 22
SG - Singapore 18
DE - Germania 9
GR - Grecia 3
DK - Danimarca 2
HK - Hong Kong 2
MX - Messico 2
TR - Turchia 2
ES - Italia 1
IE - Irlanda 1
IR - Iran 1
NZ - Nuova Zelanda 1
Totale 1.207
Salva come PNG Salva come JPEG
Città #
Olomouc 826
New York 58
Ashburn 30
Shanghai 27
Helsinki 24
Lawrence 24
Princeton 23
Singapore 10
Los Angeles 6
Boardman 5
Milan 5
Seattle 5
Rome 4
Athens 3
Columbus 3
St Louis 3
Camogli 2
Hvidovre 2
Ravenna 2
Santa Clara 2
Turin 2
Abbiategrasso 1
Bari 1
Council Bluffs 1
Falkenstein 1
Istanbul 1
Kaitangata 1
Madrid 1
Totale 1.073
Salva come PNG Salva come JPEG
Nome #
An update on treatment of ulcerative colitis 91
Corrigendum: Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial 90
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy 89
Biosimilars in IBD: Similarity Breeds Contented Patients 88
Authors' answers on comment of Abellona et al. on Metabolomic analysis for noninvasive diagnosis of hepatic fibrosis degree in patients with chronic hepatitis C 87
IBD and malignancies: The gender matters 87
Correction to: Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 85
Comparative efficacy of first-line therapeutic interventions for achalasia: a systematic review and network meta-analysis 85
Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial 85
First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus 84
Global variability of the human IgG glycome 83
Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 17
A PROLONGED FOLLOW-UP ON THE EFFICACY AND SAFETY OF INFLIXIMAB BIOSIMILAR CT-P13 IN IBD ACROSS ITALY: THE PROSIT COHORT 14
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease 14
A further "stri(v)de" in IBD management 13
The PROSIT-BIO Cohort of the IG-IBD: A Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Infliximab BioSimilars 13
Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases 13
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment 12
A multicenter randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group 12
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 12
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease 11
Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trial 11
Genetics and epigenetics of IBD 11
Risk factor analysis for therapy related adverse events and infections in elder patients with Inflammatory Bowel Disease; An analysis from the IG-IBD aged study 11
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects 10
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes 10
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications 9
Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study 9
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 9
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use 9
Adalimumab in active ulcerative colitis: A "real-life" observational study 9
Computed tomography or contrast-enhanced ultrasonography for follow-up of liver metastases after Cyberknife therapy?: A prospective pilot study 9
Optimizing biologic therapy in inflammatory bowel disease: a Delphi consensus in the United Arab Emirates 8
Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study 8
The "Hub and Spoke" model has no effect on mortality in acute upper gastrointestinal bleeding: A prospective multicenter cohort study 8
Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population 7
Prospective observational study on inflammatory bowel disease patients treated with infliximab biosimilars: preliminary results of the PROSIT-BIO cohort of the IG-IBD 7
Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease 7
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 7
Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study 6
Use of biosimilars in inflammatory bowel disease: Statements of the Italian Group for Inflammatory Bowel Disease 6
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 6
Peroral Endoscopic Myotomy for the Treatment of Esophageal Diverticula: A Systematic Review and Meta-analysis 5
TDM of Anti-TNF Agents: The Importance of Being Active! 5
Promoter methylation of the MGAT3 and BACH2 genes correlates with the composition of the immunoglobulin G glycome in inflammatory bowel disease 5
Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases 5
Prevalence and Predictors of Reduced Bone Density in Child and Adolescent Patients With Crohn's Disease 5
THE HLA-DQΒ1 INSERTION IS A STRONG ACHALASIA RISK FACTOR AND DISPLAYS A GEOSPATIAL NORTH-SOUTH GRADIENT AMONG EUROPEANS 5
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar 5
Disease patterns in late-onset ulcerative colitis: Results from the " IG-IBD ""AGED study""" 5
Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases 4
Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease 4
10-year follow-up results of the European Achalasia Trial: a multicentre randomised controlled trial comparing pneumatic dilation with laparoscopic Heller myotomy 3
Small Bowel Adenocarcinoma in Crohn's Disease: An Underestimated Risk? 3
The interaction of patients’ physical status and time to endoscopy on mortality risk in patients with upper gastrointestinal bleeding: A national prospective cohort study 2
Pre- and post-procedural quality indicators for colonoscopy: A nationwide survey 2
Long-term results of the European Achalasia trial: A multicentre randomised Controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy 2
Percutaneous ultrasound-guided fiducial marker placement for liver cancer robotic stereotactic radio-surgery treatment: A comparative analysis of three types of markers and needles 1
Emerging drug for diarrhea predominant irritable bowel syndrome 1
Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation 1
Chronic inflammatory diseases: Do immunological patterns drive the choice of biotechnology drugs? A critical review 1
Review article: The natural history of paediatric-onset ulcerative colitis in population-based studies 1
Gastrointestinal motility disorders in inflammatory bowel diseases 1
Vitamin D regulates the tight-junction protein expression in active ulcerative colitis 1
Erratum: Oral prolonged release beclomethasone dipropionate and prednisone in the treatment of active ulcerative colitis: Results from a double-blind, randomized, parallel group study (American Journal of Gastroenterology (2015) 110 (708-715) DOI: 10.1038/ajg.2015.114) 1
European evidence-based consensus: Inflammatory bowel disease and malignancies 1
Clinical features and HLA association of 5-aminosalicylate (5-ASA)-induced nephrotoxicity in inflammatory bowel disease 1
The genetic burden of inflammatory bowel diseases: implications for the clinic? 1
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment 1
Attributes of intestinal microbiota composition and their correlation with clinical primary non-response to anti-TNF-α agents in inflammatory bowel disease patients 1
Genetic variation in the lymphotoxin-α (LTA)/tumour necrosis factor-α (TNFα) locus as a risk factor for idiopathic achalasia 1
The role of glycosylation in IBD 1
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions 1
Immunoglobulin A Glycosylation Differs between Crohn’s Disease and Ulcerative Colitis 1
Association between polymorphisms in antioxidant genes and inflammatory bowel disease 1
Attitudes, perceptions and barriers in implementing therapeutic drug monitoring for anti-TNFs in inflammatory bowel disease: a survey from the Middle East 1
ECCO IBD curriculum 1
Roundtable on biosimilars with European regulators and medical societies, Brussels, Belgium, 12 January 2016 1
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: A genetic association study 1
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis 1
Disease Course and Colectomy Rate of Ulcerative Colitis: A Follow-up Cohort Study of a Referral Center in Tuscany 1
Results of the 4th Scientific Workshop of the ECCO (Group II): Markers of intestinal fibrosis in inflammatory bowel disease 1
Composition of the gut microbiota in patients with inflammatory bowel disease in Saudi Arabia: A pilot stud 1
Outcome of acute severe ulcerative colitis in patients previously exposed to immunosuppressive therapy 1
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants 1
Metabolomic analysis with 1H-NMR for non-invasive diagnosis of hepatic fibrosis degree in patients with chronic hepatitis C 1
Prospective Evaluation of Liver Stiffness Using Transient Elastography in Alcoholic Patients following Abstinence 1
Biosimilars in Italy: a gastroenterologist's view 1
Impact of genetic polymorphisms on the pathogenesis of idiopathic achalasia: Association with IL33 gene variant 1
Impact of new treatments on hospitalisation, surgery, infection, and mortality in IBD: A Focus paper by the epidemiology committee of ECCO 1
Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia 1
3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: Diagnosis and medical management 1
Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease 1
Beclomethasone dipropionate for the treatment of ulcerative colitis 1
Role of vitamin D derivatives in intestinal tissue of patients with inflammatory bowel diseases 1
Randomised controlled trial of mesalazine in IBS 1
Genetic sharing and heritability of paediatric age of onset autoimmune diseases 1
Percutaneous ultrasound-guided bowel biopsy of a pseudokidney mass 1
Ustekinumab as induction and maintenance therapy for Crohn's disease 1
Crohn's Colitis: Development of a multiplex gene expression assay comparing mRNA levels of susceptibility genes 1
Totale 1.365
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 1 0 0 0 0 0
2021/202230 0 0 0 27 0 0 0 0 0 1 0 2
2022/2023118 60 26 1 1 2 15 2 3 8 0 0 0
2023/20241.240 93 8 31 57 13 60 5 25 5 9 496 438
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 1.394